Clinical Trials on Intrahepatic Cholangiocarcinoma in Japan
Total 33 results
-
Kansai Hepatobiliary Oncology GroupCompletedIntrahepatic CholangiocarcinomaJapan
-
City of Hope Medical CenterRecruitingCholangiocarcinoma | Cholangiocarcinoma, Intrahepatic | Cholangiocarcinoma Resectable | Cholangiocarcinoma; LiverUnited States, Japan
-
City of Hope Medical CenterRecruitingHepatocellular Carcinoma | Primary Liver Cancer | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Hepatic Cancer | Hepatic Carcinoma | Primary Liver CarcinomaUnited States, Japan
-
TakedaActive, not recruitingProgressive Familial Intrahepatic Cholestasis (PFIC)Japan
-
ServierActive, not recruitingCholangiocarcinoma Non-resectable | Cholangiocarcinoma MetastaticJapan
-
Kowa Research Institute, Inc.Recruiting
-
Teikyo UniversityCompletedPrimary Biliary CirrhosisJapan
-
Chiba UniversityCompleted
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Kiminori Kimura, MDJapan Agency for Medical Research and Development; Ohara Pharmaceutical Co....CompletedLiver Cirrhosis, Biliary | Primary Biliary Cholangitis (PBC)Japan
-
Akita University HospitalHuman Genome Center, Institute of Medical Science, University of TokyoSuspendedBile Duct CancerJapan
-
Chiba UniversityCompletedPancreatic Cancer | Bile Duct CancerJapan
-
Taiho Oncology, Inc.RecruitingAdvanced Cholangiocarcinoma | FGFR2 Fusions | Gene RearrangementUnited States, Korea, Republic of, Spain, Japan, Portugal, Italy, China, Argentina, Brazil, Poland, Australia
-
Tokyo Medical and Dental UniversityWithdrawnHepatocellular Carcinoma | Cholangiocarcinoma | Gallbladder Neoplasms | HepatomaJapan
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
Taiho Oncology, Inc.Active, not recruitingAdvanced Cholangiocarcinoma | FGFR2 Gene RearrangementsUnited States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Advanced Cancer | Biliary Tract Carcinoma | Gall Bladder CarcinomaJapan
-
Eisai Co., Ltd.Active, not recruiting
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
TakedaActive, not recruiting
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand
-
EA Pharma Co., Ltd.TerminatedPrimary Biliary CholangitisJapan
-
Boehringer IngelheimCompletedGastrointestinal Neoplasms | Pancreatic Neoplasms | CholangiocarcinomaSpain, Belgium, China, United States, Germany, Korea, Republic of, France, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder CancerKorea, Republic of, United States, Taiwan, Italy, France, China, Japan, Spain, United Kingdom
-
Seagen Inc.RecruitingGastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ AdenocarcinomaUnited States, Japan
-
GlaxoSmithKlineRecruitingCholestasisUnited States, France, Japan, United Kingdom, Bulgaria, Germany, Greece, Italy, China, Argentina, Belgium, Brazil, Canada, Czechia, Israel, Mexico, Poland, Russian Federation, Spain, Switzerland
-
GlaxoSmithKlineCompletedCholestasisUnited States, Australia, France, Spain, Germany, Canada, Japan, United Kingdom, Italy, Poland
-
GlaxoSmithKlineActive, not recruitingPruritusUnited States, France, Spain, Israel, Belgium, Canada, Czechia, Italy, United Kingdom, China, Germany, Mexico, Japan, Brazil, Poland, Russian Federation, Greece, Argentina, Switzerland, Bulgaria
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingGlioma | Cholangiocarcinoma | Chondrosarcoma | Any Solid TumorUnited States, Spain, Korea, Republic of, Australia, Japan, Taiwan, France, Singapore, Hong Kong
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder CancerKorea, Republic of, United States, Taiwan, China, Argentina, Australia, Brazil, Chile, France, Germany, Italy, Japan, Poland, Spain, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Hepatocellular Carcinoma | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder NeoplasmsUnited States, Chile, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Spain, Taiwan, Turkey, Canada
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland